• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MASIMO CORPORATION RADICAL-7; OXIMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MASIMO CORPORATION RADICAL-7; OXIMETER Back to Search Results
Catalog Number LP-PBXMASI1S2P
Medical Device Problem Codes Defective Device (2588); Battery Problem (2885); Fail-Safe Problem (2936)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/08/2023
Type of Reportable Event Malfunction
Event or Problem Description
As a biomed technician i found that approximately 30% of the batteries in the masimo radical spo2 device are swelling with gasses and posing potential fire hazard.Spoke to masimo tech support and they are aware of the issue but have not enacted a recall voluntarily.I would think that due to the volatility of lithium ion batteries that are compromised this issue should receive more attention.Part number- lp-pbxmasi1s2p.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADICAL-7
Common Device Name
OXIMETER
Manufacturer (Section D)
MASIMO CORPORATION
MDR Report Key16919551
Report NumberMW5117485
Device Sequence Number6328829
Product Code DQA
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial
Report Date (Section B) 05/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberLP-PBXMASI1S2P
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/11/2023
Patient Sequence Number1
Patient SexMale
-
-